Department of Three Wards of Cardiovascular Medicine, Anyang Third People's Hospital, Anyang, China.
Clin Exp Hypertens. 2023 Dec 31;45(1):2228517. doi: 10.1080/10641963.2023.2228517.
To investigate coronary artery disease (CAD) and its correlation with the ambulatory arterial stiffness index (AASI) in patients with H-type hypertension (essential hypertension combined with hyper-homocysteinemia) and coronary heart disease (CHD).
Patients with essential hypertension and CHD who were undergoing coronary angiography were enrolled. The general clinical data, biochemical indicators, ambulatory blood pressure monitoring results and coronary angiography results of the selected patients were collected, and the AASI and Gensini scores were calculated. According to homocysteine (Hcy) levels, the patients were divided into two groups: a study group and a control group. The differences in general clinical data, biochemical indexes, AASI scores and degree of coronary artery lesions between the two groups were compared. The correlation between the AASI and the Gensini score and the relationship between the AASI and the Gensini score of CAD and various factors were analyzed.
Compared with the control group, the Hcy level in the study group was significantly increased (8.16 ± 2.33 vs 19.20 ± 2.36, = .001). The 24-h diastolic blood pressure (DBP) in the study group was significantly lower than that in the control group (76.38 ± 9.33 vs 79.91 ± 9.25, = .002), and the AASI was significantly higher than in the control group (0.62 ± 0.81 vs 0.420 ± 0.70, = .001). The number of patients having coronary stenoses with a Gensini score of ≤ 38 was significantly lower in the study group than in the control group (21.3% vs 49.4%, < .001). The number of patients with a Gensini score of ≥ 51 in the study group was significantly higher than in the control group (22.0% vs 18.8%, < .001). There was a significant positive correlation between the AASI and the Gensini score in the study group ( = 0.732, < .001). Hypertension duration (β = 0.168), diabetes history (β = 0.236), 24-h SBP (β = 0.122), 24-h DBP (β = -0.131), low-density lipoprotein cholesterol (β = 0.134) and Hcy (β = 0.233) were the influencing factors for AASI ( < .05). Both Hcy * AASI (β = 0.356) and Hcy × 24-h HR (β = 0.331) had a synergistic effect on the Gensini score ( = .017), with Hcy * AASI having a more significant effect on the Gensini score ( < .001).
The AASI was significantly increased in patients with H-type hypertension and CHD, which was associated with the severity of CAD. Therefore, Hcy levels and the AASI have a synergistic effect when evaluating the severity of CAD in patients with hypertensive CHD.
探讨 H 型高血压(原发性高血压合并高同型半胱氨酸血症)合并冠心病(CHD)患者的冠状动脉疾病(CAD)及其与动态动脉僵硬度指数(AASI)的关系。
选取行冠状动脉造影的原发性高血压合并 CHD 患者,收集入选患者的一般临床资料、生化指标、动态血压监测结果及冠状动脉造影结果,计算 AASI 及 Gensini 评分。根据同型半胱氨酸(Hcy)水平将患者分为研究组和对照组,比较两组患者一般临床资料、生化指标、AASI 评分及冠状动脉病变程度的差异,分析 AASI 与 Gensini 评分的相关性,以及 AASI 与 CAD 及各因素 Gensini 评分的关系。
与对照组相比,研究组的 Hcy 水平明显升高(8.16±2.33比 19.20±2.36, = .001)。研究组的 24 小时舒张压(DBP)明显低于对照组(76.38±9.33比 79.91±9.25, = .002),AASI 明显高于对照组(0.62±0.81比 0.420±0.70, = .001)。研究组 Gensini 评分≤38 的冠状动脉狭窄患者例数明显少于对照组(21.3%比 49.4%, < .001)。研究组 Gensini 评分≥51 的患者例数明显多于对照组(22.0%比 18.8%, < .001)。研究组 AASI 与 Gensini 评分呈显著正相关( = 0.732, < .001)。高血压病程(β = 0.168)、糖尿病史(β = 0.236)、24 小时收缩压(β = 0.122)、24 小时 DBP(β = -0.131)、低密度脂蛋白胆固醇(β = 0.134)和 Hcy(β = 0.233)是 AASI 的影响因素( < .05)。Hcy * AASI(β = 0.356)和 Hcy × 24 小时心率(β = 0.331)对 Gensini 评分均有协同作用( = .017),且 Hcy * AASI 对 Gensini 评分的影响更大( < .001)。
H 型高血压合并 CHD 患者的 AASI 明显升高,与 CAD 的严重程度有关。因此,Hcy 水平和 AASI 在评估高血压合并 CHD 患者 CAD 严重程度时具有协同作用。